Corticosteroids and low bone mineral density affect hip cartilage in systemic lupus erythematosus patients: Quantitative T2 mapping

Hagiwara, Shigeo; Nakamura, Junichi; Watanabe, Atsuya; Kishida, Shunji; Ohtori, Seiji; Omae, Takanori; Miyamoto, Shuichi; Orita, Sumihisa; Takahashi, Kazuhisa

doi:10.1002/jmri.24953

Cited by 7 publications

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Series of studies is consistency with this result [39,40] . On the other hand, this result comes in disagreement with Balasubramanian et al (2014) who represented that the reason for surgical replacement was osteoporosis caused by medications; as corticosteroid therapy and osteoporosis are independent risk factors for cartilage degeneration at the femoral head [41,42] . Notably, in this study when comparing between THR and TKR patients, there was a statistically significant difference between them at the 4 th postoperative day as TKR patients had worse problems than THR patients.…”

Section: Discussionmentioning

confidence: 97%

Early Unpleasant Postoperative Symptoms for Patients Undergoing Primary Hip versus Primary Knee Replacement: Patient Perception

Kader¹,

Shrief²,

Salama³

2017

IOSR JNHS

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 97%

Early Unpleasant Postoperative Symptoms for Patients Undergoing Primary Hip versus Primary Knee Replacement: Patient Perception

Kader¹,

Shrief²,

Salama³

2017

IOSR JNHS

View full text Add to dashboard Cite

“…Table S2: Study selection, Inclusion and Exclusion Criteria, and the reasons for exclusion of Studies at the full text Level. Table S3: Reasons for Exclusion of Papers at the full-text Level [56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73].…”

Section: Supplementary Materialsmentioning

confidence: 99%

Screening for Asymptomatic Osteonecrosis of the Hip in Systemic Lupus Erythematous: A Systematic Review and Meta-Analysis of MRI-Based Prevalence

Ibad,

Ghotbi,

Kasaeian

et al. 2024

Diagnostics

View full text Add to dashboard Cite

Objective. This paper aims to estimate asymptomatic hip osteonecrosis prevalence in SLE patients using MRI examination and to determine the prevalence among higher risk subpopulations. Materials and Methods. PubMed, Embase, Cochrane, and SCOPUS were searched from inception to May 9th, 2023. Studies on patients who were clinically diagnosed with systemic lupus erythematosus without reported symptoms attributable to hip osteonecrosis were included. Two independent reviewers extracted data and assessed the risk of bias. Data collected from each study include the study year, the number of hips screened, the number of hips with osteonecrosis, demographics, laboratory data, medications, follow-up time, radiological protocols, and MRI-based osteonecrosis detection and grading criteria. Results. Eleven eligible studies including 503 participants (15–35 years old; 74–100% female) with SLE were identified. Significant risk of bias was determined in one study. The overall prevalence of osteonecrosis of the hip was found to be 14% (184/1006 hip joints, 95% confidence interval: 7–22%, number needed to scan: 7.1). SLE patients who received corticosteroid treatment had a higher prevalence of asymptomatic hip osteonecrosis (18%) compared to non-corticosteroid users (0%, p-value < 0.01). Additionally, meta-regression results revealed that daily corticosteroid dose was associated with increased prevalence of asymptomatic osteonecrosis (0.5%/milligram, p-value < 0.01). Conclusions. The high prevalence of asymptomatic hip osteonecrosis in SLE patients raises concerns about the timeliness of interventions. The limitations of this study include a relatively low number of identified studies; and one study lacked full-text availability.

show abstract

“…Keywords: systemic lupus erythematosus; osteonecrosis; total hip arthroplasty. Установлено, что развитие ОН при СКВ ассоциируется с общей кумулятивной дозой ГК [16,23], более высокой средней суточной дозой ГК [17,24,25] и разовой дозой ГК [13,[26][27][28][29][30]. Однако кумулятивная месячная доза не ассоциировалась с развитием ОН при СКВ [10,12,31,32].…”

Section: Hip Arthroplasty In Patients With Systemic Lupus Erythematosusunclassified

Hip Arthroplasty in Patients With Systemic Lupus Erythematosus

Mukhanov

Рыбников

Попкова³

et al. 2020

Naučno-praktičeskaâ revmatologiâ

View full text Add to dashboard Cite

Corticosteroids and low bone mineral density affect hip cartilage in systemic lupus erythematosus patients: Quantitative T2 mapping

Abstract: T2 mapping suggests that corticosteroid therapy and osteoporosis are independent risk factors for cartilage degeneration at the femoral head in patients with SLE.

Cited by 7 publications

References 39 publications

Early Unpleasant Postoperative Symptoms for Patients Undergoing Primary Hip versus Primary Knee Replacement: Patient Perception

Early Unpleasant Postoperative Symptoms for Patients Undergoing Primary Hip versus Primary Knee Replacement: Patient Perception

Screening for Asymptomatic Osteonecrosis of the Hip in Systemic Lupus Erythematous: A Systematic Review and Meta-Analysis of MRI-Based Prevalence

Hip Arthroplasty in Patients With Systemic Lupus Erythematosus

Contact Info

Product

Resources

About